Spaero Bio

Business Model
B2B
Website
spaero.bio
Total Funding
$2.0M
Last Round
$2.0M Seed
Rounds
1

About

Spaero Bio develops a robot-agnostic software layer that empowers scientists and automation engineers to design, execute, and iterate liquid-handling protocols faster and with fewer errors. The platform bridges the gap between existing liquid-handler capabilities and laboratory workflow needs, enabling scientists to compose protocol steps through an intuitive UI while automation teams configure operational constraints and error-recovery rules. Spaero's self-healing runtime automatically handles recoverable errors and sends notifications when intervention is needed. Key supported workflows include aliquoting, cherry picking, plate stamping, sample reformatting, and serial dilutions.

Summary

Spaero Bio is a Biotech company. It has raised $2.0M in total across 1 round. Investors include BlueYard Capital, Compound and Cantos.

Sign up to view the funding chart

Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed Round
$2.0M

Investors

Similar Companies